22-May-2024
No headlines found.
Globe Newswire (Tue, 14-May 10:30 AM ET)
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
Globe Newswire (Mon, 13-May 8:00 AM ET)
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
Globe Newswire (Thu, 9-May 8:00 AM ET)
Attention Disc Medicine, Inc. Investors: Company Investigated by the Portnoy Law Firm
Globe Newswire (Mon, 1-Apr 3:32 PM ET)
Investigation of Disc Medicine, Inc. (IRON) Announced by Holzer & Holzer, LLC
Globe Newswire (Mon, 1-Apr 1:38 PM ET)
Globe Newswire (Mon, 1-Apr 8:00 AM ET)
Globe Newswire (Thu, 21-Mar 8:00 AM ET)
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
Globe Newswire (Wed, 6-Mar 4:30 PM ET)
Globe Newswire (Mon, 26-Feb 8:30 AM ET)
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
Disc Medicine trades on the NASDAQ stock market under the symbol IRON.
As of May 22, 2024, IRON stock price climbed to $33.17 with 295,203 million shares trading.
IRON has a beta of 1.94, meaning it tends to be more sensitive to market movements. IRON has a correlation of 0.07 to the broad based SPY ETF.
IRON has a market cap of $820.02 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that IRON belongs to (by Net Assets): XBI, VTI, IWM, VXF, IBB.
IRON has underperformed the market in the last year with a return of -1.1%, while the SPY ETF gained +28.1%. In the last 3 month period, IRON fell short of the market, returning -49.0%, while SPY returned +4.7%. However, in the most recent 2 weeks IRON has outperformed the stock market by returning +13.1%, while SPY returned +2.4%.
IRON support price is $30.10 and resistance is $32.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IRON stock will trade within this expected range on the day.